Mario Notari

1.4k total citations
11 papers, 1.0k citations indexed

About

Mario Notari is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Mario Notari has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Genetics. Recurrent topics in Mario Notari's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Mario Notari is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Mario Notari collaborates with scholars based in Italy, United States and Canada. Mario Notari's co-authors include Michael A. Caligiuri, Danilo Perrotti, Paolo Neviani, Ramasamy Santhanam, Guido Marcucci, Bradley W. Blaser, Denis‐Claude Roy, Annamaria Galietta, Rossana Trotta and Clara D. Bloomfield and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Mario Notari

10 papers receiving 1.0k citations

Peers

Mario Notari
Katherine Lazarides United States
Jorge DiMartino United States
Jordan Blum United States
Shahin Rafii United States
Tun Kiat Ko Singapore
Tracee S. Panetti United States
Fotis Asimakopoulos United States
Mario Notari
Citations per year, relative to Mario Notari Mario Notari (= 1×) peers Lucia Bianchi

Countries citing papers authored by Mario Notari

Since Specialization
Citations

This map shows the geographic impact of Mario Notari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Notari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Notari more than expected).

Fields of papers citing papers by Mario Notari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Notari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Notari. The network helps show where Mario Notari may publish in the future.

Co-authorship network of co-authors of Mario Notari

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Notari. A scholar is included among the top collaborators of Mario Notari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Notari. Mario Notari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Notari, Mario, Sylvia J. Bedford-Guaus, Ignasi Jorba, et al.. (2018). The local microenvironment limits the regenerative potential of the mouse neonatal heart. Science Advances. 4(5). eaao5553–eaao5553. 125 indexed citations
2.
Notari, Mario, et al.. (2017). Fate predetermination of cardiac myocytes during zebrafish heart regeneration. Open Biology. 7(6). 170116–170116. 8 indexed citations
3.
Notari, Mario, Julián Pulecio, & Ángel Raya. (2015). Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease. BioMed Research International. 2015. 1–15. 12 indexed citations
4.
Notari, Mario, Ying Hu, Gopinath Sutendra, et al.. (2015). iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy (ARVC)-induced sudden death. Proceedings of the National Academy of Sciences. 112(9). E973–81. 29 indexed citations
5.
Notari, Mario, Ying Hu, Min Lü, et al.. (2011). Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification. Proceedings of the National Academy of Sciences. 108(40). 16645–16650. 45 indexed citations
6.
Neviani, Paolo, Ramasamy Santhanam, Joshua J. Oaks, et al.. (2007). FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia. Journal of Clinical Investigation. 117(9). 2408–2421. 269 indexed citations
7.
Eiring, Anna M., Paolo Neviani, Ramasamy Santhanam, et al.. (2007). Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. Blood. 111(2). 816–828. 33 indexed citations
8.
Santhanam, Ramasamy, Paolo Neviani, Anna M. Eiring, et al.. (2006). FTY720, a New and Alternative Strategy for Treating Blast Crisis CML and Ph1 ALL Patients.. Blood. 108(11). 288–288. 1 indexed citations
9.
Neviani, Paolo, Ramasamy Santhanam, Rossana Trotta, et al.. (2005). The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. Cancer Cell. 8(5). 355–368. 370 indexed citations
10.
Notari, Mario, Paolo Neviani, Ramasamy Santhanam, et al.. (2005). A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood. 107(6). 2507–2516. 152 indexed citations
11.
Perri, T. Di, et al.. (1991). [Ridogrel, a new platelet antiaggregant molecule with a double mechanism of action. A pharmacological and clinical profile].. PubMed. 82(10). 533–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026